Skip to search.
 TSX Up 0.40% TSX Ventures Down 0.19%

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
7.59 Up 0.34(4.62%) May 27, 3:58PM EDT
Add to Portfolio
Prev Close:7.25
Open:7.25
Bid:7.57 x 400
Ask:7.61 x 200
1y Target Est:11.17
Beta:0.69
Next Earnings Date:N/A
Day's Range:7.19 - 7.65
52wk Range:5.04 - 8.50
Volume:32,845
Avg Vol (3m):31,171
Market Cap:267.21M
P/E (ttm):N/A
EPS (ttm):-1.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
TTHIUp 4.62%267.21M
GSKUp 1.76%107.73B
MRKUp 0.83%167.99B
PFEUp 0.56%211.21B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-1.09
Quarterly EPS Est (Jun-15) :-0.13
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback